Project Recommendation

Home » Project Recommendation » Respiratory drugs » Sodium cromoglicate solution for inhalation

Sodium cromoglicate solution for inhalation

Time: 2022-02-11

Project Recommendation
Information on the reference formulation	Common name	Sodium cromoglicate solution for inhalation
	Trade Name	Intal
	English Name	Sodium cromoglicate solution for inhalation
	Dosage form	Solution for inhalation
	Specification	2ml: 20mg
	Holder	サノフィ株式会社
	Country of marketing	Japan
	Features	【Pharmacodynamics】. It prevents the development of allergic rhinitis by inhibiting the release of chemical transmitters (histamine, etc.) associated with antigen-antibody reactions from mast cells. It also has an inhibitory effect on the activation of inflammatory cells (eosinophils, neutrophils and monocytes) from human peripheral venous blood.
	Indications	Allergic rhinitis
Generic drug registration classification		Classified 3 of Chemicals
Project advantages		Market advantage: There are no formally approved manufacturers in China according to the requirements of consistency evaluation. The drug has fewer side effects compared to similar drugs and can be used as a preventive drug for patients with allergic rhinitis. API research has almost been completed and Shanghai Baolong has mature prescription process and relevant research experience.